MACROCYCLIC MCL1 INHIBITORS FOR TREATMENT OF CANCER

• 收藏
• 分享

专利权人:

Astrazeneca AB

发明人:

HIRD, Alexander,BELMONTE, Matthew, Alan,YANG, Wenzhan,SECRIST, John, Paul,ROBBINS, Daniel, William,KAZMIRSKI, Steven, Lee,WU, Dedong,PENG, Bo,JOHANNES, Jeffrey,LAMB, Michelle, Laurae,YE, Qing,ZHENG, X

申请号：

DK17720720

公开号：

DK3445767T3

申请日:

2017.04.21

申请国别(地区):

DK

年份:

2020

代理人:

摘要：

and enantiomers and pharmaceutically acceptable salts thereof. Also disclosed are pharmaceutical compositions of 17-chloro-5,13,14,22-tetramethyl-28-oxa-2,9-dithia-5,6,12,13,22-pentaazaheptacyclo[27.7.1.14,7.011,15.016,21.020,24.030,35]octatriaconta-1(37),4(38),6,11,14,16,18,20,23,29,31,33,35-tridecaene-23-carboxylic acid, and enantiomers and pharmaceutically acceptable salts thereof, and methods of treating cancer with such compounds and compositions.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/